International Journal of Drug Delivery Technology
Volume 14, Issue 2

Kinetics Aspects in Design and Release of Nasal Drug Delivery Systems

Shubham Choudante1*, Priya Deshmukh2, Vaishali Kadam1, Harshal Tare3

1Saraswati Institute of Pharmacy, Pangri Nanded, Maharashtra, India.

2Department of Quality Assurance, School of Pharmacy, SRTM University, Nanded, Maharashtra, India.

3Dr. Harshal Tare (OPC) Pvt. Ltd., Jalgaon, Maharashtra, India. 

Received: 21st May, 2024; Revised: 01st June, 2024; Accepted: 10th June, 2024; Available Online: 25th June, 2024 

ABSTRACT

The traditional school of Indian medicine includes a sort of nasal therapy known as Nasya karma. There is a lot of recent interest in using the nasal route for administering difficult medications including tiny polar compounds, vaccines, hormones, peptides, and proteins. Nasal drug molecules are highly suited for systemic distribution and the absence of hepatic first-pass metabolism. Vaccination through the nose is thought to be a straightforward and economical method with improved patient compliance, and it may also provide immunity at numerous distant mucosal locations. Microparticle, nanoparticle, and liposomal nasal vaccination delivery technologies are now in development and show protection in animal models. Both pharmacokinetics & pharmacodynamics of nasal administration devices have been studied in-vivo by a number of different research organizations. The purpose of this review was to summarise these studies and bring attention to the work done on nasal-based formulations to better treat conditions like epilepsy, schizophrenia, and neurodegenerative diseases.

Keywords: Nasal delivery, Pharmacokinetics, Nose to CNS Delivery, Nasal vaccines. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.85

How to cite this article: Choudante S, Deshmukh P, Kadam V, Tare H. Kinetics Aspects in Design and Release of Nasal Drug Delivery Systems. International Journal of Drug Delivery Technology. 2024;14(2):1191-1197.

REFERENCES

  1. Dayal P, Pillay V, Babu RJ, Singh Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension. Aaps Pharmscitech. 2005 Dec;6:E573-85.
  2. Kiparissides C, Vasileiadou A, Karageorgos F, Serpetsi S. A computational systems approach to rational design of nose-to- brain delivery of biopharmaceutics. Industrial & Engineering Chemistry Research. 2019 Dec 17;59(6):2548-65.
  3. Indurkhya A, Patel M, Sharma P, Abed SN, Shnoudeh A, Maheshwari R, Deb PK, Tekade Influence of drug properties and routes of drug administration on the design of controlled release system. InDosage form design considerations 2018 Jan 1 (pp. 179-223). Academic Press.
  4. Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo Drug delivery. 2014 Feb 1;21(1):62-73.
  5. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of pharmacy and pharmacology. 2001 Jan;53(1):3-22.
  6. Ritschel WA. Biopharmaceutic and pharmacokinetic aspects in the design of controlled release peroral drug delivery systems. Drug Development and Industrial Pharmacy. 1989 Jan 1;15(6- 7):1073-103.
  7. Pereswetoff-Morath L. Microspheres as nasal drug delivery systems. Advanced Drug Delivery Reviews. 1998 Jan 5;29(1- 2):185-94.
  8. Ravouru N, Kondreddy P, Korakanchi D. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting. Current drug discovery technologies. 2013 Dec 1;10(4):270-82.
  9. Ahmad S, Shaikh TJ, Patil J, Meher A, Chumbhale D, Tare H. Osmotic Release Oral Tablet Formulation, Development, and Evaluation of an Antiepileptic Drug. International Journal of Drug Delivery Technology. 2023;13(1):305-312.
  10. Chen Y, Cheng G, Hu R, Chen S, Lu W, Gao S, Xia H, Wang B, Sun C, Nie X, Shen Q. A nasal temperature and pH dual-responsive in situ gel delivery system based on microemulsion of huperzine A: Formulation, evaluation, and in vivo pharmacokinetic study. Aaps Pharmscitech. 2019 Oct;20:1-2.
  11. Watts P, Smith A. PecSys: in situ gelling system for optimised nasal drug Expert opinion on drug delivery. 2009 May 1;6(5):543-52.
  12. Sonawane A, Jawale G, Devhadrao N, Bansode A, Lokhande J, Kherade D, Sathe P, Deshmukh N, Dama G, Tare Formulation and Development of Mucoadhesive Nasal Drug Delivery of Ropinirol HCl For Brain Targeting. International Journal of Applied Pharmaceutics. 2023;15(5):325-32.